EMA Moves To Boost Use Of Alternatives To Animal Testing
Alternative approaches to animal models, such as improved tests based on human and animal cells, provide opportunities to develop better and more predictive scientific tools, the European Medicines Agency says.
You may also be interested in...
Industry group AdvaMed says its Indian code on interactions between medtech companies and health care professionals is a first for the country.
Advice on the acceptability of registry-based studies as a source of evidence for regulatory purposes is included in new guidance from the European Medicines Agency.
England’s health technology assessment body said it would continue to work with Seagen to address the reasons why its newly published draft guidance has recommended against using Tukysa on the National Health Service.